These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5121120)

  • 1. [Evaluation of the anti-hypertensive effectiveness of Catapresan (ST-155)].
    Ambrosioni E; Corbara F; Perri G
    G Clin Med; 1971 Mar; 52(3):247-65. PubMed ID: 5121120
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experimentation with a new anti-hypertensive agent (St 155)].
    Vettore L
    Minerva Med; 1972 Apr; 63(29):1669-78. PubMed ID: 5025774
    [No Abstract]   [Full Text] [Related]  

  • 3. [Our first experiences with the new hypotensive drug Catapresan].
    Grujić M; Robović Z; Perinović M; Rizvanbegović B; Sarić V; Vasiljević M
    Med Arh; 1968; 22(3):75-80. PubMed ID: 5191771
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with the new antihypertensive agent Catapresan].
    Messerich J
    Med Klin; 1966 Dec; 61(52):2078-9. PubMed ID: 5999213
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical studies on the antihypertensive effect of Catapresan].
    Kreuziger H; Brehm H
    Med Welt; 1968 Apr; 14():905-7. PubMed ID: 5718198
    [No Abstract]   [Full Text] [Related]  

  • 6. [Catapresan--a new hypotensive agent].
    Tarkowska A
    Pol Tyg Lek; 1969 Jun; 24(24):934-6. PubMed ID: 4896410
    [No Abstract]   [Full Text] [Related]  

  • 7. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
    Fritsch H; Bachmann GW; Lenhard J
    Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with Catapresan].
    Laux L; Angelmann W
    Med Monatsschr; 1967 Apr; 21(4):186-7. PubMed ID: 5584446
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience with Catapresan in the therapy of hypertension].
    Michel D
    Dtsch Med Wochenschr; 1968 Jul; 93(28):1375. PubMed ID: 5657231
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term clinical study and serial determination of urinary catecholamines using the new antihypertensive agent ST-155].
    Villalpando J; Skromme D; Chávez B; Serrano P
    Arch Inst Cardiol Mex; 1968; 38(6):841-50. PubMed ID: 5711376
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of severe hypertension with Catapresan. A comparative study of the effects of Catapresan and methyldopa on ambulant hypertensive patients].
    Becker-Christensen F; Bang HO; Ditzel J
    Ugeskr Laeger; 1970 Dec; 132(49):2331-6. PubMed ID: 5488234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with a new hypotensive drug: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155)].
    Langer-Costanzi M
    Clin Ter; 1970 Dec; 55(5):419-31. PubMed ID: 5516107
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of arterial hypertension with ST-155].
    Fonnesu C; Solinas F
    Clin Ter; 1970 Sep; 54(5):455-9. PubMed ID: 4949933
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical studies on the mechanism of action of 2-(2,6-dichlorphenylamino)-2-imidazolinehydrochloric acid (Catapresan)].
    Scheja HW; Strum A
    Verh Dtsch Ges Inn Med; 1968; 74():559-62. PubMed ID: 5714381
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Palagi L; D'Elia M; Lanzara P; Criscione SM
    Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary clinical experiences on the antihypertensive effect of 2-(2-6 diclorophenylamino)-imidazoline].
    Corsini G; Di Filippo A; Cioffi A
    Rass Int Clin Ter; 1971 Feb; 51(4):237-46. PubMed ID: 5576946
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonidine (Catapres): a new antihypertensive agent.
    Khan A; Camel G; Perry HM
    Curr Ther Res Clin Exp; 1970 Jan; 12(1):10-8. PubMed ID: 4984047
    [No Abstract]   [Full Text] [Related]  

  • 18. Blind trial with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) in essential hypertension. Effects on arterial blood pressures at rest and during exercise and on physical work capacity.
    Koch G
    Arzneimittelforschung; 1970 Dec; 20(12):1857-9. PubMed ID: 5537080
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with a new antihypertensive agent].
    Lieb W; Ridders K
    Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the therapy of hypertension with an imidazoline derivative].
    Krause W; Krämer D; Grünitz B
    Med Klin; 1969 Jul; 64(28):1274-6. PubMed ID: 5799785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.